All Stories

  1. Reply to: Effect of female genital cutting performed by health care professionals on labor complications in Egyptian women: methodological concerns

    Article • Journal of Perinatal Medicine, February 2018, De Gruyter

    Dr Mohamed AFM Youssef

  2. Barbed sutures versus conventional sutures for uterine closure at cesarean section; a randomized controlled trial

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, October 2017, Taylor & Francis

    Dr Mohamed AFM Youssef

  3. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology

    Article • Cochrane Database of Systematic Reviews, October 2014, Wiley

    Dr Mohamed AFM Youssef

  4. Argon beam coagulator versus cystectomy for endometrioma treatment in infertile women and the impact on ovarian reserve. A case control study

    Article • Middle East Fertility Society Journal, March 2014, Elsevier

    Dr Mohamed AFM Youssef

  5. Primary anterior vaginal wall pure ammonium acid urate stone. Case report

    Article • Middle East Fertility Society Journal, June 2013, Elsevier

    Dr Mohamed AFM Youssef

  6. Can a dopamine agonist prevent severe ovarian hyperstimulation syndrome (OHSS) in women undergoing intracytoplasmic sperm injection (ICSI) treatment cycles?

    Article • January 2013, Springer Science + Business Media

    Dr Mohamed AFM Youssef

  7. Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis

    Article • Fertility and Sterility, April 2012, Elsevier

    Dr Mohamed AFM Youssef, Professor Waleed El-khayat

  8. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

    Article • May 2011, Wiley

    Professor Mohamed A Aboulghar, Dr Mohamed AFM Youssef

  9. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles

    Article • April 2011, Wiley

    Dr Mohamed AFM Youssef

  10. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome

    Article • February 2011, Wiley

    Professor Mohamed A Aboulghar, Dr Mohamed AFM Youssef

  11. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles

    Article • January 2011, Wiley

    Dr Mohamed AFM Youssef

  12. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles

    Article • November 2010, Wiley

    Dr Mohamed AFM Youssef

  13. Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis

    Article • Human Reproduction Update, March 2010, Oxford University Press (OUP)

    Dr Mohamed AFM Youssef

  14. Culture media for human preimplantation embryos in assisted reproductive technology cycles

    Article • July 2009, Wiley

    Dr Mohamed AFM Youssef

  15. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles

    Article • April 2005, Wiley

    Professor Mohamed A Aboulghar, Dr Mohamed AFM Youssef

  16. Intra-venous fluids preventing severe ovarian hyperstimulation syndrome

    Article • April 2002, Wiley

    Professor Mohamed A Aboulghar, Dr Mohamed AFM Youssef